A pure play branded generic marketing pharma company headquartered in Delhi with a pan India sales team of 300 medical reps with strong presence in north & east India selling brands across multiple therapeutic segments including Orthopedics with an expected turnover of Rs. 48 crores is looking for a strategic exit.
|Deal Size||INR 650 to 700 Mn|
|Motives For Sellout|
Sub-Industry: Generic Pharmaceuticals
Division`s Plant Location
|2017 (in INR)||2018 (in INR)||2019 (in INR)||2020 (in INR)|
|Sales||N.D||420 Mn||480 Mn||N.D|